Phase I/II clinical trial of encapsulated, cytochrome P450 expressing cells as local activators of cyclophosphamide to treat spontaneous canine tumours.
Based upon promising preclinical studies, a clinical trial was performed in which encapsulated cells overexpressing cytochrome P450 enzyme isoform 2B1 were implanted around malignant mammary tumours arising spontaneously in dogs. The dogs were then given cyclophosphamide, one of the standard chemoth...
Guardado en:
Autores principales: | Monika Michałowska, Stanislaw Winiarczyk, Łukasz Adaszek, Wojciech Łopuszyński, Zbigniew Grądzki, Brian Salmons, Walter H Günzburg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4b821ea2311f40ed8bb05cb522000c32 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Utility of urinary markers in the assessment of renal dysfunction in familial glomerulonephritis in Dobermann dogs
por: Winiarczyk Dagmara, et al.
Publicado: (2020) -
The impact of camptothecin-encapsulated poly(lactic-co-glycolic acid) nanoparticles on the activity of cytochrome P450 in vitro
por: Bao H, et al.
Publicado: (2019) -
Epizootic situation of feline Bartonella infection in eastern Poland
por: Mazurek Łukasz, et al.
Publicado: (2020) -
The cytochrome P450 (CYP) superfamily in cnidarians
por: Kirill V. Pankov, et al.
Publicado: (2021) -
An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase
por: Goutam Mukherjee, et al.
Publicado: (2021)